28469422|t|Seroprevalence of Asymptomatic Dengue Virus Infection and Its Antibodies Among Healthy / Eligible Saudi Blood Donors: Findings From Holy Makkah City
28469422|a|Threat to blood transfusion - transmitted dengue virus (DENV) and its antibodies has recently emerged worldwide. Dengue fever is an endemic disease in Saudi Arabia, particularly in its Western region. The aim of this study was to estimate the seroprevalence of asymptomatic DENV infection and its antibodies among eligible Saudi blood donors. Serum samples from 910 healthy / eligible adult male Saudi blood donors, who reside in Holy Makkah City of Saudi Arabia, were collected between March 2015 and August 2016 and screened for the detection of DENV nonstructural protein 1 (NS1) antigen and anti-DENV IgM and IgG antibodies using commercial enzyme-linked immunosorbent assay kits (Panbio, Brisbane, QLD, Australia). Among the tested donors, 48 (5.3%) were seropositive for DENV-NS1 antigen, whereas 50 (5.5%) and 354 (38.9%) were seropositive for anti-DENV IgM and IgG antibodies, respectively. Seropositivity for DENV-NS1 antigen and/or anti-DENV IgM antibody among the tested donors reflects their ongoing asymptomatic viremic infectious stage with DENV during their donation time, whereas high prevalence of anti-DENV IgG seropositivity reflects the high endemicity of dengue disease in this region of Saudi Arabia. These results show high prevalence of asymptomatic DENV infection and its antibodies among Saudi blood donors, raising the importance of establishing blood screening for dengue disease at different blood donation services and units in Saudi Arabia to improve the guarantee of blood transfusions and to control DENV dissemination.
28469422	0	14	Seroprevalence	T062	C0600367
28469422	18	30	Asymptomatic	T033	C0231221
28469422	31	43	Dengue Virus	T005	C0011315
28469422	44	53	Infection	T047	C0042769
28469422	62	72	Antibodies	T116,T129	C0003241
28469422	79	86	Healthy	T080	C3898900
28469422	89	97	Eligible	T080	C1548635
28469422	98	103	Saudi	T083	C0036243
28469422	104	116	Blood Donors	T098	C0005795
28469422	132	148	Holy Makkah City	UnknownType	C0681784
28469422	149	155	Threat	T078	C0749385
28469422	159	176	blood transfusion	T061	C0005841
28469422	179	190	transmitted	T046	C0242781
28469422	191	203	dengue virus	T005	C0011315
28469422	205	209	DENV	T005	C0011315
28469422	219	229	antibodies	T116,T129	C0003241
28469422	262	274	Dengue fever	T047	C0011311
28469422	281	296	endemic disease	T047	C0277550
28469422	300	312	Saudi Arabia	T083	C0036243
28469422	334	348	Western region	UnknownType	C0681784
28469422	379	387	estimate	T081	C0750572
28469422	392	406	seroprevalence	T062	C0600367
28469422	410	422	asymptomatic	T033	C0231221
28469422	423	427	DENV	T005	C0011315
28469422	428	437	infection	T047	C0042769
28469422	446	456	antibodies	T116,T129	C0003241
28469422	463	471	eligible	T080	C1548635
28469422	472	477	Saudi	T083	C0036243
28469422	478	490	blood donors	T098	C0005795
28469422	492	505	Serum samples	T031	C1550100
28469422	515	522	healthy	T080	C3898900
28469422	525	533	eligible	T080	C1548635
28469422	534	539	adult	T100	C0001675
28469422	540	544	male	T032	C0086582
28469422	545	550	Saudi	T083	C0036243
28469422	551	563	blood donors	T098	C0005795
28469422	579	595	Holy Makkah City	UnknownType	C0681784
28469422	599	611	Saudi Arabia	T083	C0036243
28469422	684	693	detection	T061	C1511790
28469422	697	739	DENV nonstructural protein 1 (NS1) antigen	T116,T129	C3869773
28469422	744	757	anti-DENV IgM	T116,T129	C0003241
28469422	762	776	IgG antibodies	T116,T129	C0003241
28469422	794	832	enzyme-linked immunosorbent assay kits	T059	C0014441
28469422	857	866	Australia	T083	C0004340
28469422	879	892	tested donors	T098	C0005795
28469422	909	921	seropositive	T080	C0521143
28469422	926	942	DENV-NS1 antigen	T116,T129	C3869773
28469422	983	995	seropositive	T080	C0521143
28469422	1000	1013	anti-DENV IgM	T116,T129	C0003241
28469422	1018	1032	IgG antibodies	T116,T129	C0003241
28469422	1048	1062	Seropositivity	T080	C0521143
28469422	1067	1083	DENV-NS1 antigen	T116,T129	C3869773
28469422	1091	1113	anti-DENV IgM antibody	T116,T129	C0003241
28469422	1124	1137	tested donors	T098	C0005795
28469422	1161	1173	asymptomatic	T033	C0231221
28469422	1174	1198	viremic infectious stage	T047	C0012634
28469422	1204	1208	DENV	T005	C0011315
28469422	1222	1230	donation	T058	C0005794
28469422	1231	1235	time	T079	C0040223
28469422	1245	1260	high prevalence	T081	C1512456
28469422	1264	1277	anti-DENV IgG	T116,T129	C0003241
28469422	1278	1292	seropositivity	T080	C0521143
28469422	1311	1321	endemicity	T047	C0277550
28469422	1325	1339	dengue disease	T047	C0011311
28469422	1358	1370	Saudi Arabia	T083	C0036243
28469422	1391	1406	high prevalence	T081	C1512456
28469422	1410	1422	asymptomatic	T033	C0231221
28469422	1423	1427	DENV	T005	C0011315
28469422	1428	1437	infection	T047	C0042769
28469422	1446	1456	antibodies	T116,T129	C0003241
28469422	1463	1468	Saudi	T083	C0036243
28469422	1469	1481	blood donors	T098	C0005795
28469422	1522	1537	blood screening	T059	C1511226
28469422	1542	1556	dengue disease	T047	C0011311
28469422	1570	1593	blood donation services	T058	C0005794
28469422	1607	1619	Saudi Arabia	T083	C0036243
28469422	1648	1666	blood transfusions	T061	C0005841
28469422	1682	1686	DENV	T005	C0011315
28469422	1687	1700	dissemination	T080	C0332261